IN8bio - 53 Year Dividend History | INAB
Historical dividend payout and yield for IN8bio (INAB) since 1971. The current TTM dividend payout for IN8bio (INAB) as of November 29, 2024 is $0.00. The current dividend yield for IN8bio as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.022B |
$0.000B |
|
IN8bio Inc. is a clinical-stage biotechnology company. It focuses on developing therapies for the treatment of cancers, including solid tumors using allogeneic, autologous, and genetically modified gamma-delta T cells. The company's principal candidate includes INB-200, which are in clinical stage. IN8bio Inc. is based in New York.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
